MétaCan
Menu
Back to cohort
Record W2052376711 · doi:10.1002/ijc.27817

Feasibility of real time next generation sequencing of cancer genes linked to drug response: Results from a clinical trial

2012· article· en· W2052376711 on OpenAlexaff
Ben Tran, Andrew Brown, Philippe L. Bédard, Eric Winquist, Glenwood D. Goss, Sebastién J. Hotte, Stephen Welch, Hal W. Hirte, Tong Zhang, Lincoln Stein, Vincent Ferretti, Stuart Watt, Wei Jiao, Karen Ng, Sangeet Ghai, Patricia Shaw, Teresa Petrocelli, Thomas J. Hudson, Benjamin G. Neel, Nicole Onetto, Lillian L. Siu, John D. McPherson, Suzanne Kamel‐Reid, Janet Dancey

Bibliographic record

VenueInternational Journal of Cancer · 2012
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicCancer Genomics and Diagnostics
Canadian institutionsJuravinski Cancer CentreOttawa HospitalPrincess Margaret Cancer CentreQueen's UniversityLondon Health Sciences CentreOntario Institute for Cancer ResearchToronto General HospitalUniversity of TorontoUniversity Health Network
FundersMinistero dello Sviluppo Economico
KeywordsSanger sequencingMedicineGenotypingLiquid biopsyMultiplexOncologyDNA sequencingPrecision medicinePersonalized medicineExonBiopsyIon semiconductor sequencingGeneInternal medicineBioinformaticsCancerGeneticsBiologyPathologyGenotype

Abstract

fetched live from OpenAlex

The successes of targeted drugs with companion predictive biomarkers and the technological advances in gene sequencing have generated enthusiasm for evaluating personalized cancer medicine strategies using genomic profiling. We assessed the feasibility of incorporating real-time analysis of somatic mutations within exons of 19 genes into patient management. Blood, tumor biopsy and archived tumor samples were collected from 50 patients recruited from four cancer centers. Samples were analyzed using three technologies: targeted exon sequencing using Pacific Biosciences PacBio RS, multiplex somatic mutation genotyping using Sequenom MassARRAY and Sanger sequencing. An expert panel reviewed results prior to reporting to clinicians. A clinical laboratory verified actionable mutations. Fifty patients were recruited. Nineteen actionable mutations were identified in 16 (32%) patients. Across technologies, results were in agreement in 100% of biopsy specimens and 95% of archival specimens. Profiling results from paired archival/biopsy specimens were concordant in 30/34 (88%) patients. We demonstrated that the use of next generation sequencing for real-time genomic profiling in advanced cancer patients is feasible. Additionally, actionable mutations identified in this study were relatively stable between archival and biopsy samples, implying that cancer mutations that are good predictors of drug response may remain constant across clinical stages.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.001
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.113
Threshold uncertainty score0.371

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.117
GPT teacher head0.419
Teacher spread0.302 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations81
Published2012
Admission routes1
Has abstractyes

Explore more

Same venueInternational Journal of CancerSame topicCancer Genomics and DiagnosticsFrench-language works237,207